Literature DB >> 29226975

Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics.

C Bon1, P L Toutain2, D Concordet3,4,5, R Gehring6, T Martin-Jimenez7, J Smith8, L Pelligand2, M Martinez9, T Whittem10, J E Riviere6, J P Mochel11.   

Abstract

A common feature of human and veterinary pharmacokinetics is the importance of identifying and quantifying the key determinants of between-patient variability in drug disposition and effects. Some of these attributes are already well known to the field of human pharmacology such as bodyweight, age, or sex, while others are more specific to veterinary medicine, such as species, breed, and social behavior. Identification of these attributes has the potential to allow a better and more tailored use of therapeutic drugs both in companion and food-producing animals. Nonlinear mixed effects (NLME) have been purposely designed to characterize the sources of variability in drug disposition and response. The NLME approach can be used to explore the impact of population-associated variables on the relationship between drug administration, systemic exposure, and the levels of drug residues in tissues. The latter, while different from the method used by the US Food and Drug Administration for setting official withdrawal times (WT) can also be beneficial for estimating WT of approved animal drug products when used in an extralabel manner. Finally, NLME can also prove useful to optimize dosing schedules, or to analyze sparse data collected in situations where intensive blood collection is technically challenging, as in small animal species presenting limited blood volume such as poultry and fish.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  covariates; nonlinear mixed effects; population pharmacokinetics; sparse sampling; veterinary medicine

Mesh:

Year:  2017        PMID: 29226975     DOI: 10.1111/jvp.12473

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  11 in total

1.  Pharmacokinetics of tulathromycin in pregnant ewes (Ovis aries) challenged with Campylobacter jejuni.

Authors:  Michael Yaeger; Jonathan P Mochel; Zuowei Wu; Paul Plummer; Orhan Sahin; Joseph Smith; Melda Ocal; Ashenafi Beyi; Changyun Xu; Qijing Zhang; Ronald W Griffith
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

2.  Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols.

Authors:  Felix Held; Carl Ekstrand; Marija Cvijovic; Johan Gabrielsson; Mats Jirstrand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-23       Impact factor: 2.745

3.  Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer.

Authors:  Benjamin K Schneider; Arnaud Boyer; Joseph Ciccolini; Fabrice Barlesi; Kenneth Wang; Sebastien Benzekry; Jonathan P Mochel
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-05-09

4.  Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs.

Authors:  Jianzhong Wang; Benjamin K Schneider; Jiao Xue; Pan Sun; Jicheng Qiu; Jonathan P Mochel; Xingyuan Cao
Journal:  Front Vet Sci       Date:  2019-10-17

Review 5.  Understanding Volume Kinetics: The Role of Pharmacokinetic Modeling and Analysis in Fluid Therapy.

Authors:  Xiu Ting Yiew; Shane W Bateman; Robert G Hahn; Alexa M E Bersenas; William W Muir
Journal:  Front Vet Sci       Date:  2020-11-20

6.  Enrofloxacin Dose Optimization for the Treatment of Colibacillosis in Broiler Chickens Using a Drinking Behaviour Pharmacokinetic Model.

Authors:  Robin Temmerman; Ludovic Pelligand; Wim Schelstraete; Gunther Antonissen; An Garmyn; Mathias Devreese
Journal:  Antibiotics (Basel)       Date:  2021-05-19

7.  Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination.

Authors:  Petra Cagnardi; Federica Di Cesare; Pierre-Louis Toutain; Alain Bousquet-Mélou; Giuliano Ravasio; Roberto Villa
Journal:  Front Pharmacol       Date:  2018-10-09       Impact factor: 5.810

8.  In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs.

Authors:  Margaret L Musser; Alyssa L Mahaffey; Melissa A Fath; Garry R Buettner; Brett A Wagner; Benjamin K Schneider; Yeon-Jung Seo; Jonathan P Mochel; Chad M Johannes
Journal:  Front Vet Sci       Date:  2019-11-07

9.  Population Pharmacokinetic Modelling of Orally Administered Doxycycline to Rabbits at Different Ages.

Authors:  Rositsa Mileva; Anton Rusenov; Aneliya Milanova
Journal:  Antibiotics (Basel)       Date:  2021-03-17

10.  Prednisolone in Dogs-Plasma Exposure and White Blood Cell Response.

Authors:  Carl Ekstrand; Helena Pettersson; Ronette Gehring; Mikael Hedeland; Sara Adolfsson; Inger Lilliehöök
Journal:  Front Vet Sci       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.